DURECT CORP
10-Q, EX-27.1, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: DURECT CORP, 10-Q, 2000-11-14
Next: FIRST DEPOSIT BANCSHARES INC, 10QSB, 2000-11-14



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENS INCLUDED IN PART I, ITEM 1 OF FORM 10-Q DATED SEPTEMBER 30,
2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.

*Identify the financial statement(s) to be referenced in the legend;
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          19,320
<SECURITIES>                                     6,014
<RECEIVABLES>                                      933
<ALLOWANCES>                                      (82)
<INVENTORY>                                      3,096
<CURRENT-ASSETS>                               106,774
<PP&E>                                           2,894
<DEPRECIATION>                                   (622)
<TOTAL-ASSETS>                                 116,137
<CURRENT-LIABILITIES>                            3,609
<BONDS>                                              0
                                0
                                          0
<COMMON>                                             4
<OTHER-SE>                                     111,601
<TOTAL-LIABILITY-AND-EQUITY>                   116,137
<SALES>                                          2,182
<TOTAL-REVENUES>                                 2,182
<CGS>                                            1,417
<TOTAL-COSTS>                                    1,417
<OTHER-EXPENSES>                                16,916
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                (88)
<INCOME-PRETAX>                               (14,917)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (14,917)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (14,917)
<EPS-BASIC>                                     (1.96)
<EPS-DILUTED>                                   (1.96)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission